February 25, 2014
In recent years, there’s been quite a bit of buzz around Big Pharma’s expansion into BRIC countries – Brazil, Russia, India and China. For industry superstars, emerging markets have proven fertile ground for clinical research, manufacturing, drug discovery, and numerous other outsourced operations. But as activity begins to slow in the BRIC, Pharma is already.....